Cited by 27

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation

Na, Hana, Yang, Jack B., Zhang, Zhengrong, Gan, Qini, Tian, Hua, Rajab, Ibraheem M., Potempa, Lawrence A., Tao, Qiushan, Qiu, Wei Qiao·2023·Neurobiology of Aging

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2023.02.013

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Alam, 2018, Proximity ligation assay (PLA), Curr. Protoc. Immunol., 123, 10.1002/cpim.58 · DOI
  2. Beishon, 2021, The Neurovascular Unit in Dementia: an Opinion on current research and future directions, Front. Aging Neruosci., 13, 721937, 10.3389/fnagi.2021.721937 · DOI
  3. Bergers, 2005, The role of pericytes in blood-vessel formation and maintenance, Neuro. Oncol., 7, 452, 10.1215/S1152851705000232 · DOI · Paper page
  4. Caprio, 2018, pCRP-mCRP dissociation mechanisms as potential targets for the development of small-molecule anti-inflammatory chemotherapeutics, Front. Immunol., 9, 1089, 10.3389/fimmu.2018.01089 · DOI
  5. Chirco, 2016, Monomeric C-reactive protein and inflammation in age-related macular degeneration, J. Pathol., 240, 173, 10.1002/path.4766 · DOI
  6. Christie, 1996, Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer’s disease, J. Neuropathol. Exp. Neurol., 55, 491, 10.1097/00005072-199604000-00012 · DOI · Paper page
  7. DeKosky, 1990, Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity, Ann. Neurol., 27, 457, 10.1002/ana.410270502 · DOI · Paper page
  8. Fan, 2001, Expression and regulation of apolopoprotein E receptors in the cells of the central nervous system in culture: A review, J. Am. Aging Asoc., 24, 1
  9. Giannisis, 2022, Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice, Mol. Psychiatry, 27, 3533, 10.1038/s41380-022-01548-0 · DOI
  10. Hart, 2020, C-reactive protein and cancer-diagnostic and therapeutic insights, Front. Immunol., 11, 595835, 10.3389/fimmu.2020.595835 · DOI
  11. Hussain, 2021, Blood-Brain Barrier Breakdown: an Emerging biomarker of cognitive impairment in normal aging and dementia, Front. Neurosci., 15, 688090, 10.3389/fnins.2021.688090 · DOI
  12. Kanekiyo, 2012, LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer’s amyloid-β, J. Neurosci., 32, 16458, 10.1523/JNEUROSCI.3987-12.2012 · DOI · Paper page
  13. Kannel, 1979, An investigation of coronary heart disease in families. The Framingham offspring study, Am. J. Epidemiol., 110, 281, 10.1093/oxfordjournals.aje.a112813 · DOI
  14. Kloske, 2020, The important interface between apolipoprotein E and neuroinflammation in Alzheimer’s disease, Front. Immunol., 11, 754, 10.3389/fimmu.2020.00754 · DOI · Paper page
  15. Lane-Donovan, 2016, High-fat diet changes hippocampal apolipoprotein E (ApoE) in a genotype- and carbohydrate-dependent manner in mice, PLoS One, 11, 10.1371/journal.pone.0148099 · DOI
  16. Lazaris, 2015, Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding, Neurol. Genet., 1, 10.1212/NXG.0000000000000022 · DOI
  17. Li, 2021, Development of novel therapeutics targeting the blood-brain barrier: From barrier to carrier, Adv. Sci., 8, e2101090, 10.1002/advs.202101090 · DOI · Paper page
  18. Maier, 2013, LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype, Mol. Neurodegener., 8, 25, 10.1186/1750-1326-8-25 · DOI · Paper page
  19. May, 2004, Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice, Mol. Cell Biol., 24, 8872, 10.1128/MCB.24.20.8872-8883.2004 · DOI · Paper page
  20. Pflanzner, 2011, LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier, Neurobiol. Aging, 32, 2323.e1, 10.1016/j.neurobiolaging.2010.05.025 · DOI · Paper page
  21. Potempa, 2021, C-reactive protein and cancer: interpreting the differential bioactivities o its pentameric and monomeric, modified isoforms, Front. Immunol., 12, 744129, 10.3389/fimmu.2021.744129 · DOI
  22. Potempa, 2015, Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification, Biophys. Rep., 1, 18, 10.1007/s41048-015-0003-2 · DOI
  23. Prendecki, 2019, APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer’s disease, Folia Neuropathol., 57, 106, 10.5114/fn.2019.84828 · DOI
  24. Rajab, 2020, How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression, Front. Immunol., 11, 2126, 10.3389/fimmu.2020.02126 · DOI
  25. Reddy, 2008, Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease, Trends Mol. Med., 14, 45, 10.1016/j.molmed.2007.12.002 · DOI · Paper page
  26. Riedel, 2016, Age, APOE, and sex: triad of risk of Alzheimer’s disease, J. Steroid Biochem. Mol. Biol., 160, 134, 10.1016/j.jsbmb.2016.03.012 · DOI · Paper page
  27. Salloway, 2002, Effect of APOE genotype on microvascular basement membrane in Alzheimer’s disease, J. Neurol. Sci., 203–204, 183, 10.1016/S0022-510X(02)00288-5 · DOI · Paper page
  28. Selkoe, 2016, The amyloid hypothesis of Alzheimer’s disease at 25 years, EMBO Mol. Med., 8, 595, 10.15252/emmm.201606210 · DOI · Paper page
  29. Slevin, 2009, A role for monomeric C-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease?, Histol. Histopathol., 24, 1473
  30. Slevin, 2010, Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro, Brain Pathol., 20, 151, 10.1111/j.1750-3639.2008.00256.x · DOI
  31. Slevin, 2015, Monomeric C-reactive protein – a key molecule driving development of Alzheimer’s disease associated with brain ischaemia?, Sci. Rep., 5, 13281, 10.1038/srep13281 · DOI · Paper page
  32. Stephensen, 2000, Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey, Am. J. Clin. Nutr., 72, 1170, 10.1093/ajcn/72.5.1170 · DOI
  33. Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
  34. Swanson, 1988, Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization, Proc. Natl. Acad. Sci. USA, 85, 9821, 10.1073/pnas.85.24.9821 · DOI
  35. Tai, 2015, APOE-modulated Aβ-induced neuroinflammation in Alzheimer’s disease: current landscape, novel data, and future perspective, J. Neurochem., 133, 465, 10.1111/jnc.13072 · DOI · Paper page
  36. Tang, 2017, C-reactive protein and ageing, Clin. Exp. Pharmacol. Physiol., 1, 9, 10.1111/1440-1681.12758 · DOI
  37. Tanzi, 1999, A genetic dichotomy model for the inheritance of Alzheimer’s disease and common age-related disorders, J. Clin. Invest., 104, 1175, 10.1172/JCI8593 · DOI
  38. Terry, 1991, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol., 30, 572, 10.1002/ana.410300410 · DOI · Paper page
  39. Torres, 2020, ApoE isoform-specifi differences in behavior and cognition associated with subchronic MPTP exposure, Learn. Mem., 27, 372, 10.1101/lm.052126.120 · DOI
  40. Wang, 2015, Increased monomeric CRP levels in acute myocardial infarction: a possible new and specific biomarker for diagnosis and severity assessment of disease, Atherosclerosis, 239, 343, 10.1016/j.atherosclerosis.2015.01.024 · DOI
  41. Williams, 2020, Therapeutic approaches targeting apolipoprotein E function in Alzheimer’s disease, Mol. Neurodegener., 15, 8, 10.1186/s13024-020-0358-9 · DOI
  42. Wu, 2015, C-reactive protein and inflammation: conformational changes affect function, Biol. Chem., 396, 1181, 10.1515/hsz-2015-0149 · DOI
  43. Yang, 2016, LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways, J. Neuroinflammation, 13, 304, 10.1186/s12974-016-0772-7 · DOI · Paper page
  44. Zhang, 2021, Monomeric C-reactive protein via endothelial CD31for neurovascular inflammation in an ApoE genotype-dependent pattern: a risk factor for Alzheimer’s disease?, Aging Cell, 20, 10.1111/acel.13501 · DOI · Paper page
  45. Zieba, 2018, In situ protein detection with enhanced specificity using DNA-conjugated antibodies and proximity ligation, Mod. Pathol., 31, 253, 10.1038/modpathol.2017.102 · DOI
  46. Zipser, 2007, Microvascular injury and blood-brain barrier leakage in Alzheimer’s disease, Neurobiol. Aging, 28, 977, 10.1016/j.neurobiolaging.2006.05.016 · DOI · Paper page

Metadata

Authors
Na, H., Yang, J. B., Zhang, Z., Gan, Q., Tian, H., Rajab, I. M., Potempa, L. A., Tao, Q., & Qiu, W. Q.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2023-07
Volume
127
Pages
54-69
ISSN
0197-4580
Cited by
27
References
14
Language
en
Funders
  • Boston University
  • NIH
  • National Institute on Aging (AG-008122, AG-022476, AG-16495)
  • National Heart, Lung, and Blood Institute (N01-HC-25195)
  • National Institute of Neurological Disorders and Stroke (NS-17950)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review